ACT Stock - Enact Holdings, Inc.
Unlock GoAI Insights for ACT
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.20B | $1.15B | $1.09B | $1.12B | $1.11B |
| Gross Profit | $940.31M | $903.38M | $949.75M | $748.55M | $490.66M |
| Gross Margin | 78.2% | 78.3% | 86.7% | 66.8% | 44.3% |
| Operating Income | $878.06M | $851.51M | $898.22M | $695.22M | $472.42M |
| Net Income | $688.07M | $665.51M | $704.16M | $546.68M | $370.42M |
| Net Margin | 57.2% | 57.7% | 64.3% | 48.8% | 33.5% |
| EPS | $4.40 | $4.14 | $4.32 | $3.36 | $2.27 |
Enact Holdings, Inc. operates as a private mortgage insurance company in the United States. The company is involved in writing and assuming residential mortgage guaranty insurance. It offers private mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; and contract underwriting services for mortgage lenders. The company was formerly known as Genworth Mortgage Holdings, Inc. and changed its name to Enact Holdings, Inc. in May 2021. Enact Holdings, Inc. was founded in 1981 and is headquartered in Raleigh, North Carolina. Enact Holdings, Inc. is a subsidiary of Genworth Holdings, Inc.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| May 5th 2025 | Keefe Bruyette | Downgrade | Market Perform | $39 |
| December 6th 2023 | UBS | Initiation | Neutral | $29 |
| November 13th 2023 | BofA Securities | Upgrade | Buy | $30 |
| May 9th 2023 | BofA Securities | Upgrade | Neutral | $27← $25 |
| February 8th 2023 | Keefe Bruyette | Upgrade | Outperform | $26.5← $25 |
| January 9th 2023 | Credit Suisse | Downgrade | Underperform | $24.5 |
| September 6th 2022 | JP Morgan | Downgrade | Neutral | $27 |
| August 18th 2022 | BofA Securities | Downgrade | Underperform | $25 |
| July 18th 2022 | Keefe Bruyette | Downgrade | Market Perform | $27← $28 |
Earnings History & Surprises
ACTEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 28, 2026 | — | — | — | — |
Q1 2026 | Feb 3, 2026 | $1.09 | — | — | — |
Q4 2025 | Nov 5, 2025 | $1.12 | $1.12 | 0.0% | = MET |
Q3 2025 | Jul 30, 2025 | $1.11 | $1.15 | +3.6% | ✓ BEAT |
Q2 2025 | Apr 30, 2025 | $1.12 | $1.10 | -1.8% | ✗ MISS |
Q1 2025 | Feb 4, 2025 | $1.02 | $1.09 | +6.9% | ✓ BEAT |
Q3 2024 | Jul 31, 2024 | $0.99 | $1.27 | +28.3% | ✓ BEAT |
Q2 2024 | May 1, 2024 | $0.96 | $1.04 | +8.3% | ✓ BEAT |
Q1 2024 | Feb 6, 2024 | $0.92 | $0.98 | +6.5% | ✓ BEAT |
Q4 2023 | Nov 1, 2023 | $0.89 | $1.02 | +14.6% | ✓ BEAT |
Q3 2023 | Aug 1, 2023 | $0.84 | $1.04 | +23.8% | ✓ BEAT |
Q2 2023 | May 3, 2023 | $0.80 | $1.08 | +35.0% | ✓ BEAT |
Q1 2023 | Feb 6, 2023 | $0.84 | $0.88 | +4.8% | ✓ BEAT |
Q4 2022 | Nov 1, 2022 | $0.87 | $1.17 | +34.5% | ✓ BEAT |
Q3 2022 | Aug 1, 2022 | $0.86 | $1.25 | +45.3% | ✓ BEAT |
Q2 2022 | May 3, 2022 | $0.84 | $1.01 | +20.2% | ✓ BEAT |
Q1 2022 | Feb 1, 2022 | $0.83 | $0.94 | +13.3% | ✓ BEAT |
Q4 2021 | Nov 2, 2021 | $0.81 | $0.84 | +3.7% | ✓ BEAT |
Q3 2021 | Sep 17, 2021 | — | $0.80 | — | — |
Q1 2021 | Mar 31, 2021 | — | $0.77 | — | — |
Latest News
Keefe, Bruyette & Woods Maintains Market Perform on Enact Holdings, Raises Price Target to $43
📈 PositiveJP Morgan Maintains Neutral on Enact Holdings, Lowers Price Target to $39
➖ NeutralEnact Holdings Q3 Adj. EPS $1.12 Beats $1.09 Estimate, Sales $311.455M Miss $311.978M Estimate
➖ NeutralFrequently Asked Questions about ACT
What is ACT's current stock price?
What is the analyst price target for ACT?
What sector is Enact Holdings, Inc. in?
What is ACT's market cap?
Does ACT pay dividends?
Similar Stocks
Financial Services SectorExplore stocks similar to ACT for comparison